In AD patients, the level TGF-β is enhanced in the CSF, serum and brain microvascular endothelial cells which induces secretion of pro-inflammatory cytokines (IL-1β and TGF-α) [330]. The gene discussed is IL1B; the disease is Alzheimer disease.